Key Points: In today’s Recommendations for Industry, we discuss what the COVID case increase in the New England States means for the U.S. Read more
Key Points: In today’s Recommendations for Industry, we discuss the “blip” in U.S. COVID cases, despite the fact that BA.2 has become the dominant variant.
Key Points: In today’s Recommendations for Industry, we discuss the ongoing need for symptom monitoring. Read more below. The CDC will extend its mask-use on
Key Points: In today’s Recommendations for Industry, we discuss a return to normal. Read more below. In a recent paper published in JAMA Neurology, CIDRAP
Key Points: In today’s Recommendations for Industry, we discuss the current “transition” status of COVID-19, mask mandates, and recommendations. Read more below. Is the Coronavirus
Key Points: In today’s Recommendations for Industry, we discuss new studies suggesting that flu shots, measles vaccines, and the common cold can cross-protect against COVID.
Key Points: In today’s Recommendations for Industry, we discuss the Omicron variant. Read more below. On Sunday Jan 09, the CDC updated its “Quarantine and
Key Points: In today’s Recommendations for Industry, we discuss CDC’s COVID updates in which it recommends shortening isolation from 10 days for people with COVID-19
Key Points In today’s Recommendations for Industry, we discuss the possibility of a “twindemic” and how businesses can prepare. Read more below. The Omicron variant
Key Points In today’s Recommendations for Industry, we discuss the rise of Omicron. Read more here. COVID deaths in the US surpass 800,000 (NYT). It
